Versant Venture Management as of Dec. 31, 2014
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 5 positions in its portfolio as reported in the December 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Clovis Oncology | 43.6 | $46M | 815k | 56.00 | |
| Five Prime Therapeutics | 28.2 | $30M | 1.1M | 27.00 | |
| Achaogen | 16.0 | $17M | 1.3M | 13.05 | |
| Cymabay Therapeutics | 9.9 | $10M | 1.0M | 9.83 | |
| Kythera Biopharmaceuticals I | 2.3 | $2.4M | 70k | 34.68 |
